Cathie Wood Sees $400B Opportunity In Biologics — How Have Her Bets Fared?

BenzingaNov 26 22:37 ET

Morgan Stanley Maintains Adaptive Biotechnologies(ADPT.US) With Hold Rating, Maintains Target Price $7

Moomoo NewsNov 19 03:36 ET · Ratings

Balanced Hold Recommendation for Adaptive Biotechnologies Amid Positive Performance and External Challenges

TipRanksNov 18 20:47 ET · Ratings

Life Sciences Stocks Viewed Positively at TD Cowen Despite Post-election Weakness

Seeking AlphaNov 15 15:55 ET

Scotiabank Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Maintains Target Price $10

Moomoo NewsNov 12 07:36 ET · Ratings

Adaptive Biotechnologies Corporation's (NASDAQ:ADPT) 31% Jump Shows Its Popularity With Investors

Simply Wall StNov 12 06:30 ET